Welcome to our dedicated page for Praxis Impact International ETF news (Ticker: PRXI), a resource for investors and traders seeking the latest updates and insights on Praxis Impact International ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Praxis Impact International ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Praxis Impact International ETF's position in the market.
Praxis (NYSE:PRXI) launched the Praxis Impact International ETF, its first ETF focused on developed markets outside North America. The fund began trading on NYSE Arca and applies Praxis’s faith-based stewardship investing values and ImpactX framework.
PRXI tracks the Morningstar Developed Markets ex-North America Target Market Exposure Index using optimized, quantitative equity strategies, excludes emerging markets, is sub-advised by Vident Asset Management, and has an expense ratio of 0.54%.